cGxP.wire https://validator.w3.org/feed/docs/rss2.html Laekna Showcases Novel Oral Obesity Candidate LAE124 Caristo AI Score Improves Heart Risk Prediction in 19,110 Antengene Presents ATG-207 Preclinical Data at ACR 2026 Skribe Advances Wearable Heart Monitoring for Cancer Patients Lupus Research Alliance Awards Prize for TLR7 Discovery Shanton Pharma Wins FDA and EMA Waivers for SAP-001 Abbott Wins FDA Approval for UltiSynq Heart Device Lead Metagenomi Gains FDA IND Clearance for Hemophilia A Beeline Reports Positive Phase 2 Results for Afimetoran Nimbus Starts Phase 1 Trial of Oral SIK2 Inhibitor Drug Pfizer Secures $1.5B Blackstone Funding for Obesity Drug CU Anschutz Publishes Roadmap for Pediatric Diabetes Immunotherapy Ascletis Submits Oral Obesity Drug Combination to FDA AI4Eyes Completes FDA Registration for AI Eye Care Platform Amgen Reports Positive Phase 3 Dazodalibep Results: Sjögren Lilly Reports One-Year Results for Taltz and Zepbound Waters Wins FDA Clearance for Leukemia Flow Cytometry Tests Lipocine Starts Phase 3 BLOOM Trial for Postpartum Depression Adcendo to Present ADCE-D01 Phase 1 Sarcoma Data Azitra Reports ATR-COSF Results for Wrinkle Reduction Francis Medical Secures J&J Funding to Expand Vanquish Ambrosia Presents Two Oral Obesity Drug Candidates in 2026 Layer Health Wins 2026 Accenture HealthTech Innovation Award 10x Genomics Launches 500-Patient Breast Cancer Study Jubilant Therapeutics Reports Promising JBI-802 Clinical Data Novo Nordisk Commits $200M to Global Diabetes Care Programs Moderna Reports mNEXSPIKE COVID-19 Vaccine Study Results IASO Bio Wins China IND Approval for IASO208 CAR-T CU Anschutz Study Reveals Maternal Effects in Type 1 Diabetes Eli Lilly Highlights Foundayo in New Weight-Health Campaigns Cepheid Gains IVDR CE Mark for Respiratory Panel Curia Expands Precision Fermentation Capacity in Spain Boehringer’s SCOVELLA Gains Positive EU Opinion Alnylam Reports Five-Year AMVUTTRA Benefits in ATTR-CM Eilean Reports First Human MALT1 Degradation Alphyn’s Zabalafin Highlighted in Atopic Dermatitis Review Biond Biologics Doses First Patient in BND-67 Trial HotSpot Therapeutics Reports HST-2011 Preclinical Data Protalix Reports 12-Week Uric Acid Control With PRX-115 Pierre Fabre and XtalPi Partner in AI Drug Discovery UCB Reports Sustained BIMZELX Responses in Psoriatic Arthritis Bayer Wins FDA Approval for Asundexian in Stroke Prevention Boehringer Reports Positive Survodutide Phase III Data Merck Reports Positive Efinopegdutide MASH Trial Data Valneva Reports 94% IXCHIQ Antibody Response at Five Years Actinium Forms Scientific Board to Guide Cancer Pipeline Aisa Pharma Reports Positive Phase II Data for AISA-021 Caris Reveals ESR1 Mutation Insights in Breast Cancer AbelZeta Reports CAR-T Data in Advanced Liver Cancer Lilly’s Foundayo Shows Positive Phase III Sleep Apnea Data